Sputnik V vaccine
New Delhi: The Corrid Institute of India (SII) has applied to the Drug Drug General of India (DCGI) for a trial license to manufacture the Sputnik-V vaccine. On Thursday, the Press Trust of India quoted sources as saying. According to sources, the Seram Institute of India on Wednesday applied for DCGI approval to manufacture 19 Sputnik-V covid vaccines in India. Russia’s Sputnik-V vaccine is currently being developed by Dr. Reddy’s laboratories. CM Arvind Kejriwal’s announcement, Delhi will get Sputnik V vaccine after June 20.
The Serum Institute has sought permission from the DCGI for test analysis and testing. If it is allowed to proceed, an Emergency Use Approval (EUA) will be required, the Financial Express reported.
Serum Institute of India has applied to the Drug Controller General of India for permission to manufacture COVID-19 Sputnik V: Sources
– Press Trust of India (pTI_news) June 3, 2021
Meanwhile, the Serum Institute plans to make 100 million covshield vaccines by June. Meanwhile, SII is developing the NovaVax vaccine, but is awaiting regular approval from the United States.
Recently, India received about 3 million doses of Sputnik-V from Russia. The dose arrived at Telangana’s Hyderabad airport in a specially chartered cargo.
Let us tell you that most of the states in the country currently have shortage of COVID-19 vaccine. Ongoing vaccination campaigns for 16 plus in several states have also been stopped. States are expected to receive a large number of vaccines soon.